Controlled Drugs Report 2024: CQC Flags Cross-Border Risks and Rising Fraud
The latest CQC report highlights oversight findings on controlled drugs, including increased ADHD prescribing, rising paramedic prescriptions, and concerns over fraud, end-of-life access, and cross-border data gaps. Key recommendations aim to strengthen safety and accountability.
 
  
 